TIDMHIK

RNS Number : 6675Q

Hikma Pharmaceuticals Plc

22 June 2020

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Release of a pledge Darhold Limited over 3,500,000 
       transaction               Ordinary Shares of 10 pence each in Hikma Pharmaceuticals 
                                 PLC in favour of Citibank N.A. Darhold Limited 
                                 is defined as a Person Closely Associated with 
                                 the Executive Chairman, who is a director and 
                                 shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 3,500,000 
 d)   Aggregated information    Aggregated volume: 3,500,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   22 June 2020 
 f)   Place of the              Amman 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Release of a pledge Darhold Limited over 3,500,000 
       transaction               Ordinary Shares of 10 pence each in Hikma Pharmaceuticals 
                                 PLC in favour of Citibank N.A. Darhold Limited 
                                 is defined as a Person Closely Associated with 
                                 the Executive Vice Chairman, who is a director 
                                 and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 3,500,000 
 d)   Aggregated information    Aggregated volume: 3,500,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   22 June 2020 
 f)   Place of the              Amman 
       transaction 
 

Mohammed 'Ali' Al-Husry

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mohammed 'Ali' Al-Husry 
 2    Reason for the notification 
 a)   Position/status           Non-Executive Director 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Release of a pledge Darhold Limited over 3,500,000 
       transaction               Ordinary Shares of 10 pence each in Hikma Pharmaceuticals 
                                 PLC in favour of Citibank N.A. Darhold Limited 
                                 is defined as a Person Closely Associated with 
                                 the Non-Executive Director, who is a director 
                                 and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 3,500,000 
 d)   Aggregated information    Aggregated volume: 3,500,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   22 June 2020 
 f)   Place of the              Amman 
       transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBGGDLDDDDGGD

(END) Dow Jones Newswires

June 22, 2020 06:24 ET (10:24 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Ott 2020 a Nov 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Nov 2019 a Nov 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals